Meiji Yasuda Life Insurance’s Jazz Pharmaceuticals JAZZ Stock Holding History

Meiji Yasuda Life Insurance’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-2,780	Closed	-$415K	–	285
2019 Q4	$415K	Sell	2,780 -270	-9%	-$36.7K	0.06%	246
2019 Q3	$391K	Buy	+3,050	New	+$409K	0.06%	253
2019 Q2	–	Sell	-3,138	Closed	-$449K	–	321
2019 Q1	$449K	Sell	3,138 -230	-7%	-$30K	0.07%	240
2018 Q4	$417K	Sell	3,368 -262	-7%	-$38.9K	0.06%	240
2018 Q3	$610K	Buy	3,630 +220	+6%	+$37.8K	0.08%	226
2018 Q2	$588K	Sell	3,410 -30	-0.9%	-$4.9K	0.08%	218
2018 Q1	$519K	Buy	3,440 +260	+8%	+$38.1K	0.08%	221
2017 Q4	$428K	Buy	3,180 +320	+11%	+$44.4K	0.06%	264
2017 Q3	$418K	Buy	+2,860	New	+$433K	0.06%	243

Other funds holding JAZZ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Meiji Yasuda Life Insurance's JAZZ Position: Q1 2020 in Review

Meiji Yasuda Life Insurance sold out of Jazz Pharmaceuticals (JAZZ) in Q1 2020, closing a stake of 2,780 shares — an estimated $415K sold.

Meiji Yasuda Life Insurance first reported a position in JAZZ in Q3 2017 and held it in 9 quarters. The position peaked at $610K in Q3 2018. 408 funds tracked by Wall St. Rank hold JAZZ as of Q1 2020.

Meiji Yasuda Life Insurance reported no remaining Jazz Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
Meiji Yasuda Life Insurance sold 2,780 Jazz Pharmaceuticals shares in Q1 2020, an estimated $415K.
Meiji Yasuda Life Insurance first reported a position in Jazz Pharmaceuticals in Q3 2017 and held it in 9 quarters.
Meiji Yasuda Life Insurance's Jazz Pharmaceuticals position peaked at $610K in Q3 2018.
408 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2020.

Based on Meiji Yasuda Life Insurance's 13F filing for Q1 2020, filed 14 May 2020.